BMY

Bristol-Myers Squibb Co.

PHARMACEUTICAL PREPARATIONS -5.0% (1Y)
Confidence Score
76%
Current Price
$53.94
Open
$54.21
Day Range
$53.91 - $54.35
Volume
7,859,897
Market Cap
$109.81B
Employees
34,100
Website
www.bms.com

Company Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Analysis Summary

Patent cliff concerns overblown. Opdivo combinations and new launches offset Revlimid decline. Trading at 7x forward earnings.

Pro Analysis Locked

Upgrade to Pro to unlock detailed financial analysis, historical data, comparable companies, and AI-generated research reports.